查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1866534

自體輸血裝置市場－2025-2030年預測

Auto Transfusion Devices Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

自體輸血設備市場預計將從 2025 年的 6.2225 億美元成長到 2030 年的 8.3389 億美元，複合年成長率為 6.03%。

受全球心血管疾病發生率上升的推動，自體輸血裝置市場正經歷顯著成長。世界衛生組織（WHO）的數據顯示，心血管疾病每年導致約1,790萬人死亡，佔全球死亡總數的31%。這些裝置用於在手術過程中採集並回輸患者自身的血液，從而降低感染疾病傳播的風險，並消除同種異體致敏的風險，因此得到了廣泛應用。此外，開發中國家醫療保健投入的增加也透過改善先進醫療技術的可近性，推動了市場擴張。

本報告檢驗了自體輸血設備市場當前的需求、供應和銷售趨勢，以及影響該市場發展的最新動態。報告全面分析了關鍵促進因素、限制因素和機遇，並深入探討了不同地區的行業趨勢、政策和法規，使相關人員能夠深入了解法律規範和影響市場環境的關鍵因素。

我們的競爭情報是基於廣泛的二手資料研究，旨在識別主要企業及其收入貢獻。資訊來源包括產業協會分析、分析師報告、投資者報告、新聞稿和學術期刊。我們採用自下而上和自上而下的方法計算了自體輸血設備行業及其主要細分市場的市場規模。相關數據已透過國際自體輸血設備價值鏈相關人員的第一手資訊進行檢驗。我們全面的市場分析整合了多種資訊來源和專有資料集，並運用資料三角驗證法，以提供準確的市場區隔和預測。

本報告運用分析說明、圖表和圖形，深入剖析全球自體輸血設備市場的動態。報告分析了各類設備類型和技術的需求，包括術中、術後和急診自體輸血系統，以及在醫院、門診手術中心和專科診所的應用領域。此外，報告還分析了技術進步、政府政策、法規結構和宏觀經濟因素。

本報告為業內專業人士提供關於市場趨勢、監管環境和競爭動態的關鍵洞察。報告重點闡述了心血管疾病發病率上升和醫療基礎設施投資（尤其是在發展中地區）帶來的成長機會。報告採用嚴謹的分析方法，結合一手和二手數據，確保提供可靠的洞察，幫助相關人員應對複雜的監管環境、競爭壓力和投資重點，從而在一個對透過創新血液管理解決方案改善手術效果和病患安全至關重要的市場中做出明智的決策。

本報告的主要優勢：

  • 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
  • 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
  • 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
  • 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
  • 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及影響、新產品開發、競爭影響

分析範圍

  • 歷史資料（2022-2024 年）和預測資料（2025-2030 年）
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按業務板塊和地區（國家）分類的收入成長和預測分析
  • 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

第5章 自體輸血裝置市場：依類型分類

  • 介紹
  • 手術過程中
  • 術後

第5章 自體輸血裝置市場：依應用分類

  • 介紹
  • 心血管外科
  • 整形外科手術
  • 神經外科
  • 器官移植
  • 其他

第7章 按終端用戶產業分類的自體輸血設備市場

  • 介紹
  • 醫院
  • 門診手術中心
  • 其他

第8章 自體輸血裝置市場：依地區分類

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他

第9章：競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第10章：公司簡介

  • Medline Industries, LP
  • Medtronic plc
  • Haemonetics Corporation
  • Fresenius Kabi AG
  • Terumo Corporation
  • LivaNova
  • Atrium Medical
  • BD
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.

第11章 分析方法

簡介目錄
Product Code: KSI061611959

The Auto Transfusion Devices Market is set to increase from USD 622.250 million in 2025 to USD 833.890 million by 2030, registering a 6.03% CAGR.

The autotransfusion devices market is experiencing significant growth, driven by the rising global prevalence of cardiovascular diseases, which, according to the World Health Organization, account for approximately 17.9 million deaths annually, or 31% of global mortality. These devices, used to collect and reinfuse a patient's own blood during surgical procedures, are increasingly adopted due to their ability to reduce the risk of infectious disease transmission and eliminate isosensitization risks. Additionally, growing healthcare investments in developing countries bolster market expansion by enhancing access to advanced medical technologies.

This research examines current trends in demand, supply, and sales, alongside recent developments shaping the autotransfusion devices market. It provides a comprehensive analysis of key drivers, restraints, and opportunities. The study details industry trends, policies, and regulations across geographical regions, offering stakeholders a thorough understanding of the regulatory framework and critical factors influencing the market environment.

Competitive intelligence identifies major industry players and their revenue contributions, derived from extensive secondary research. Sources include industry association studies, analyst reports, investor presentations, press releases, and journals. Market size for the overall autotransfusion devices sector and its key segments was determined using both bottom-up and top-down methodologies. Values were validated with primary inputs from stakeholders in the global autotransfusion devices value chain. Comprehensive market engineering integrated data from diverse sources and proprietary datasets, employing data triangulation for accurate market breakdown and forecasting.

Market insights are presented through analytical narratives, charts, and graphics, enabling efficient comprehension of global autotransfusion devices market dynamics. The report explores demand across various device types and technologies, including intraoperative, postoperative, and emergency autotransfusion systems, as well as applications in hospitals, ambulatory surgical centers, and specialty clinics. It also investigates technological advancements, government policies, regulatory frameworks, and macroeconomic factors.

This report equips industry experts with critical insights into market trends, regulatory landscapes, and competitive dynamics. It highlights growth opportunities driven by the increasing burden of cardiovascular diseases and healthcare infrastructure investments, particularly in developing regions. The rigorous methodology, blending primary and secondary data, ensures reliable findings, enabling stakeholders to navigate regulatory complexities, competitive pressures, and investment priorities in a market vital to improving surgical outcomes and patient safety through innovative blood management solutions.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Type

  • Intraoperative
  • Postoperative

By Application

  • Cardiovascular Surgery
  • Orthopedic Surgery
  • Neurology Surgery
  • Organ Transplantation
  • Others

By End-User Industry

  • Hospitals
  • Ambulatory Surgery Centres
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. AUTO TRANSFUSION DEVICES MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Interoperative
  • 5.3. Postoperative

5. AUTO TRANSFUSION DEVICES MARKET BY APPLICATION

  • 5.1. Introduction
  • 5.2. Cardiovascular Surgery
  • 5.3. Orthopedic Surgery
  • 5.4. Neurology Surgery
  • 5.5. Organ Transplantation
  • 5.5. Others

7. AUTO TRANSFUSION DEVICES MARKET BY END-USER INDUSTRY

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Ambulatory Surgery Centres
  • 7.4. Others

8. AUTO TRANSFUSION DEVICES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. Japan
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Taiwan
    • 8.6.6. Thailand
    • 8.6.7. Indosneisa
    • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Medline Industries, LP
  • 10.2. Medtronic plc
  • 10.3. Haemonetics Corporation
  • 10.4. Fresenius Kabi AG
  • 10.5. Terumo Corporation
  • 10.6. LivaNova
  • 10.7. Atrium Medical
  • 10.8. BD
  • 10.9. Stryker Corporation
  • 10.10. Zimmer Biomet Holdings, Inc.

11. RESEARCH METHODOLOGY